Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May;53(5):605-612.
doi: 10.1002/ppul.23960. Epub 2018 Feb 6.

Risk Scoring Tool to Predict Respiratory Syncytial Virus Hospitalisation in Premature Infants

Affiliations
Free PMC article

Risk Scoring Tool to Predict Respiratory Syncytial Virus Hospitalisation in Premature Infants

Maarten O Blanken et al. Pediatr Pulmonol. .
Free PMC article

Abstract

Background: The objective was to develop a risk scoring tool which predicts respiratory syncytial virus hospitalisation (RSVH) in moderate-late preterm infants (32-35 weeks' gestational age) in the Northern Hemisphere.

Methods: Risk factors for RSVH were pooled from six observational studies of infants born 32 weeks and 0 days to 35 weeks and 6 days without comorbidity from 2000 to 2014. Of 13 475 infants, 484 had RSVH in the first year of life. Logistic regression was used to identify the most predictive risk factors, based on area under the receiver operating characteristic curve (AUROC). The model was validated internally by 100-fold bootstrapping and externally with data from a seventh observational study. The model coefficients were converted into rounded multipliers, stratified into risk groups, and number needed to treat (NNT) calculated.

Results: The risk factors identified in the model included (i) proximity of birth to the RSV season; (ii) second-hand smoke exposure; and (iii) siblings and/or daycare. The AUROC was 0.773 (sensitivity: 68.9%; specificity: 73.0%). The mean AUROC from internal bootstrapping was 0.773. For external validation with data from Ireland, the AUROC was 0.707 using Irish coefficients and 0.681 using source model coefficients. Cut-off scores for RSVH were ≤19 for low- (1.0%), 20-45 for moderate- (3.3%), and 50-56 (9.5%) for high-risk infants. The high-risk group captured 62.0% of RSVHs within 23.6% of the total population (NNT 15.3).

Conclusions: This risk scoring tool has good predictive accuracy and can improve targeting for RSVH prevention in moderate-late preterm infants.

Keywords: bronchiolitis; lower respiratory tract infection; prematurity; risk assessment; risk factors.

Figures

Figure 1
Figure 1
Receiver operating characteristic (ROC) curve for the final three‐variable model derived from the pooled dataset
Figure 2
Figure 2
Risk factor scoring tool. Key: 0 = no/not present; 1 = yes/present for one risk factor; 2 = yes/present for both risk factors
Figure 3
Figure 3
Interpretation of risk score and risk group characteristics (Please note that it is not possible to achieve a score of 46‐49 based on the individual variable scores)

Similar articles

See all similar articles

Cited by 3 articles

References

    1. Shi T, McAllister DA, O'Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet. 2017; 390:946–958. - PMC - PubMed
    1. Jain S, Williams DJ, Arnold SR, et al. Community‐acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015; 372:835–845. - PMC - PubMed
    1. Hasegawa K, Tsugawa Y, Brown DF, Mansbach JM, Camargo CA Jr. Trends in bronchiolitis hospitalizations in the United States, 2000–2009. Pediatrics. 2013; 132:28–36. - PMC - PubMed
    1. Figueras‐Aloy J, Manzoni P, Paes B, et al. Defining the risk and associated morbidity and mortality of severe respiratory syncytial virus infection among preterm infants without chronic lung disease or congenital heart disease. Infect Dis Ther. 2016; 5:417–452. - PMC - PubMed
    1. Palmer L, Hall CB, Katkin JP, et al. Respiratory outcomes, utilization and cost 12 months following a respiratory syncytial virus diagnosis among commercially insured late‐preterm infants. Curr Med Res Opin. 2011; 27:403–412. - PubMed

Publication types

Substances

Feedback